United States News All stories

Tapestry (NYSE:TPR) reported fiscal 2026 revenue of $8 billion, up 14% year over year, as Coach brand sales increased and the company expanded margins.

Applied Industrial Technologies (NYSE:AIT) reported fiscal 2026 fourth-quarter sales of $1.4 billion and full-year sales of $5 billion, with both periods showing year-over-year growth.

Global Net Lease (NYSE:GNL) completed its acquisition of Modiv Industrial on August 12, 2026, adding an industrial net-lease portfolio valued at approximately $535 million and expanding its industrial property exposure.

Xunlei (NASDAQ:XNET) reported second-quarter 2026 revenue of $102.7 million, up 38.9% year over year, while recording a net loss from continuing operations of $218.5 million mainly due to investment valuation changes.

Dynatrace (NYSE:DT) agreed to acquire Arize for $915 million in a cash and stock transaction, combining AI observability and application monitoring capabilities across the artificial intelligence development lifecycle.

China Automotive Systems (NASDAQ:CAAS) reported record first-half 2026 net sales of $412.5 million, up 20.1% year over year, as electric power steering sales increased and profitability improved.

Rockwell Medical (NASDAQ:RMTI) reported second-quarter 2026 net sales of $17.8 million, up 11% year over year, as the healthcare company increased sales to new and existing dialysis customers.

Semtech (NASDAQ:SMTC) agreed to sell its cellular module business to Compal Electronics for $62 million in cash as part of a portfolio shift toward data center networking and LoRa connectivity.

Suzano (NYSE:SUZ) reported second-quarter 2026 revenue of R$11.6 billion, adjusted EBITDA of R$4.7 billion, and net income of R$1.8 billion as pulp and paper sales volumes increased.

Cullinan Therapeutics (NASDAQ:CGEM), Taiho Oncology, and Taiho Pharmaceutical announced that the global Phase 3 REZILIENT3 trial of zipalertinib plus platinum-based chemotherapy met its primary endpoint of progression-free survival in previously untreated patients with EGFR exon 20 insertion non-small cell lung cancer.

Global Water Resources (NASDAQ:GWRS) reported second-quarter 2026 total revenue of $17.8 million, up 24.8% year over year, as higher regulated revenue, acquisitions, and customer growth contributed to results.

Willamette Valley Vineyards (NASDAQ:WVVI) reported a second-quarter 2026 net loss of $1.39 million, compared with net income of $92,795 in the prior-year period, as net sales declined to $10 million.

Belite Bio (NASDAQ:BLTE) reported second-quarter 2026 results and announced that the U.S. Food and Drug Administration accepted its New Drug Application for tinlarebant with Priority Review for Stargardt disease type 1.

Duolingo (NASDAQ:DUOL) announced the acquisition of Animade, a London-based animation and motion design studio, to expand its in-house Design Studio and support product experience development.

Pharming (NASDAQ:PHAR) announced the commercial launch of Joenja (leniolisib) in Japan for patients aged 4 years and older with activated PI3K delta syndrome (APDS), following its inclusion on Japan’s National Health Insurance drug price list.

Uber Technologies (NYSE:UBER) announced that Uber Japan has partnered with Hinomaru Kotsu to manage fleet operations for an autonomous vehicle pilot in Tokyo scheduled to begin in late 2026.

X-energy (NASDAQ:XE) reported second-quarter 2026 total revenues and grant income of $54.6 million, up 154% from $21.5 million a year earlier, as activity increased under its U.S. Department of Energy cost-share agreement for the Xe-100 reactor project.

Beyond Air (NASDAQ:XAIR) reported second-quarter 2026 revenue of $1.8 million, broadly unchanged from the prior-year period, while gross margin improved to 13%.

Cisco (NASDAQ:CSCO) reported record fiscal 2026 results, with annual revenue reaching $63.3 billion, up 12% year over year, as fourth-quarter revenue increased to $17.3 billion.

STAAR Surgical (NASDAQ:STAA) reported second-quarter 2026 net sales of $93.5 million, up 111% year over year, while net income improved to $8.1 million from a $16.8 million loss a year earlier.

Pharvaris (NASDAQ:PHVS) reported second-quarter 2026 results with cash and cash equivalents of €318 million as of June 30, 2026, while advancing clinical programs for its oral bradykinin B2 receptor antagonist deucrictibant.

Local Bounti (NYSE:LOCL) reported second-quarter 2026 sales of $13.9 million, up 14% year-over-year and 4% sequentially, supported by higher production in Georgia, Texas and Washington.

Oracle (NYSE:ORCL) plans double-digit job cuts this month to fund a massive data center buildout.

Neonode (NASDAQ:NEON) reported second-quarter 2026 revenue from continuing operations of $0.5 million, down 20.4% year-over-year, with license revenue increasing to $0.4 million.